Frontiers in Oncology | Hematologic Malignancies

Original Research

Published on 06 Mar 2025

Associations of ANGPT2 expression and its variants (rs1868554 and rs7825407) with multiple myeloma risk and outcome

in Hematologic Malignancies

Sylwia Popek-Marciniec
Wojciech Styk
Sylwia Chocholska
Aneta Szudy-Szczyrek
Katarzyna Sidor
Grazyna Swiderska-Kolacz
Marek Hus
Joanna Czerwik-Marcinkowska
Szymon Zmorzynski

Frontiers in Oncology

doi 10.3389/fonc.2025.1468373

1,710 views

Review

Published on 05 Mar 2025

Lipid metabolism in multiple myeloma: pathogenesis, therapeutic opportunities, and future directions

in Hematologic Malignancies

Huiquan Wang
Jiafeng Zhang
Hefei Ren
Lei Chen
Jigang Ren
Chang Liu
Hongkun Wu
Lin Zhou

Frontiers in Oncology

doi 10.3389/fonc.2025.1531928

3,546 views
2 citations

Review

Published on 03 Mar 2025

Advancing the understanding and management of angioimmunoblastic T-cell lymphoma: insights into its pathogenesis, clinical features, and emerging therapeutic strategies

in Hematologic Malignancies

Yurou Xing
Junmeng Huang
Yi Zhang
Yongsheng Wang
Shaochong Qi

Frontiers in Oncology

doi 10.3389/fonc.2025.1479179

5,985 views
1 citation

Original Research

Published on 03 Mar 2025

Retrospective study of chidamide-containing regimens as maintenance therapy among T- and NK-cell lymphoma patients

in Hematologic Malignancies

Tao Hai
Wanchun Wu
Kexin Ren
Na Li
Liqun Zou

Frontiers in Oncology

doi 10.3389/fonc.2025.1507418

1,512 views
1 citation

Original Research

Published on 28 Feb 2025

Identification of subgroups of early-stage mycosis fungoides patients with increased itch and impaired quality of life

in Hematologic Malignancies

Julia Nenonen
Anna H. Winther
Pontus Jonsson
Lina U. Ivert
Hanna Brauner

Frontiers in Oncology

doi 10.3389/fonc.2025.1524353

1,969 views
1 citation

Original Research

Published on 27 Feb 2025

Tumor gene expression signatures associated with outcome in large B−cell lymphoma treated with CD19-directed CAR T−cell therapy (axicabtagene ciloleucel)

in Hematologic Malignancies

Yuan Tian
Justin Budka
Frederick L. Locke
Jason R. Westin
Christina To
Gayatri Tiwari
Daqin Mao
Davide Bedognetti
Rhine R. Shen
Jorge Andrade

Frontiers in Oncology

doi 10.3389/fonc.2025.1519473

6,077 views
2 citations

Original Research

Published on 26 Feb 2025

Prognostic impact of initial platelet count and post-induction platelet recovery in elderly AML patients: associated with circulating cytokines

in Hematologic Malignancies

Chun Ling
Neng-Neng Cao
Xiao-Wei Niu
Shi-Yun Xu
Wen-Yu Gong
Wen-Qiang Bao
Qi-Chuan Jin
Yin Wang
Jing Wu
Chang-Zhi Zhao

Frontiers in Oncology

doi 10.3389/fonc.2025.1534158

2,620 views

Editorial

Published on 26 Feb 2025

Editorial: MDS: new scientific and clinical developments

in Hematologic Malignancies

Sabine Blum
Argiris Symeonidis
Ulrich Germing

Frontiers in Oncology

doi 10.3389/fonc.2025.1568681

1,761 views

Case Report

Published on 25 Feb 2025

Mast cell leukemia: a rare case report and literature review

in Hematologic Malignancies

Lu Tian
Xiang Yan
Shaodan Tian
Yang Shen
Qiuyue Fan

Frontiers in Oncology

doi 10.3389/fonc.2025.1537301

2,627 views

Case Report

Published on 24 Feb 2025

Case Report: A case series on histiocytic sarcoma – various clinical features and patient outcomes

in Hematologic Malignancies

Hohyung Nam
Gi-June Min
Tong Yoon Kim
Youngwoo Jeon
Seok-Goo Cho

Frontiers in Oncology

doi 10.3389/fonc.2025.1505737

3,207 views
5 citations

Original Research

Published on 21 Feb 2025

Exploration of risk factors and characteristics of COVID-19 infection among patients with hematological malignancies in Suzhou, China: a retrospective study

in Hematologic Malignancies

Yao Yao
Wenjuan Di
Fangkai He
Bin Liu
Xue Chen
Xiaojun Guan
Zhou Huang
Ying Wang
Depei Wu

Frontiers in Oncology

doi 10.3389/fonc.2024.1487516

2,045 views

Original Research

Published on 21 Feb 2025

Association of ANA and SSA autoantibodies with progression-free survival in multiple myeloma: a retrospective cohort study

in Hematologic Malignancies

Jiafeng Zhang
Hefei Ren
Lei Chen
Xin Wang
Huiquan Wang
Hongkun Wu
Lin Zhou

Frontiers in Oncology

doi 10.3389/fonc.2025.1529678

2,222 views
1 citation

Review

Published on 20 Feb 2025

Influence of CAR T-cell therapy associated complications

in Hematologic Malignancies

Mohammad Mussab Umair
Xun Lai
YuanBo Xue
Hong Yao

Frontiers in Oncology

doi 10.3389/fonc.2025.1494986

7,155 views
2 citations

Original Research

Published on 18 Feb 2025

Prognostic value of serum lipids in newly diagnosed acute promyelocytic leukemia

in Hematologic Malignancies

Shijie Wang
Qian Wang
Shuxin Lv
Ling Qin

Frontiers in Oncology

doi 10.3389/fonc.2025.1522239

1,924 views
3 citations

Original Research

Published on 17 Feb 2025

Longitudinal study of cognitive and mental functions among adult Hodgkin-lymphoma survivors, based on data from a primary treatment center in Hungary

in Hematologic Malignancies

István Virga
Karolina Kósa
Anna Illés
Zsófia Miltényi
Tibor Ivánka
Roland Berecz
Anikó Égerházi
Árpád Illés
Ferenc Magyari

Frontiers in Oncology

doi 10.3389/fonc.2025.1509424

2,602 views

Review

Published on 14 Feb 2025

The impact of multiple myeloma drugs treatments on autologous stem cell transplantation in the era of new drugs

in Hematologic Malignancies

Xixi Wan
Tian Yu
Tao Yu
Huili Cai

Frontiers in Oncology

doi 10.3389/fonc.2025.1479164

2,915 views

Case Report

Published on 13 Feb 2025

Radiotherapy as a primary treatment modality for a young man with a primary urethral plasmacytoma: case report and literature review

in Hematologic Malignancies

Soo How Lim
Tian Er Poh
Hong Chin Wee
Nur Shazwaniza Binti Awang Basry
Mohd Syazwan Bin Tajul Arifin
Kar Ying Yong

Frontiers in Oncology

doi 10.3389/fonc.2025.1528536

1,343 views

Brief Research Report

Published on 11 Feb 2025

A novel truncated fusion gene ETV6::AC010198.2 in post-MPN acute myeloid leukemia caused by del(12)(p13p11)

in Hematologic Malignancies

Jiao Lu
Guanqun Yang
Qiurong Zhang
Man Wang
Lijun Wang
Lu Chen
Haoyue Chen
Xin Jiang
Chunhua Liu
Tong Lin

Frontiers in Oncology

doi 10.3389/fonc.2025.1495182

1,776 views

Original Research

Published on 07 Feb 2025

Psychometric properties and meaningful change thresholds for the QOL-E instrument in patients with myelodysplastic neoplasms

in Hematologic Malignancies

Esther Natalie Oliva
Shien Guo
Jennifer Lord-Bessen
Aylin Yucel
Roberto Latagliata
Massimo Breccia
Giuseppe A. Palumbo
Grazia Sanpaolo
Marta Riva
Valeria Santini

Frontiers in Oncology

doi 10.3389/fonc.2025.1507854

1,919 views
1 citation

Case Report

Published on 04 Feb 2025

Unusual symptoms reveal a rare splenic lymphoma: a case report of PS-DLBCL with neck and shoulder pain as the initial presentation

in Hematologic Malignancies

Shifu Hu
Yuanyuan Hao
Xiangyu Liu
Hanbo Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1449966

2,008 views
1 citation

Systematic Review

Published on 31 Jan 2025

Prognostic and clinicopathological role of soluble programmed cell death ligand-1 in patients with diffuse large B-cell lymphoma: a meta-analysis

in Hematologic Malignancies

Hongbin Lu
Lulu Luo
Jie Mi
Min Sun
Huaping Wang
Zheng Wang
Wenwen Ding

Frontiers in Oncology

doi 10.3389/fonc.2025.1506799

1,799 views
1 citation

Case Report

Published on 30 Jan 2025

Daratumumab treatment for kidney-involved light chain deposition disease prevents renal function progression: a case report with 3 years of follow-up and review of the literature

in Hematologic Malignancies

Xueying Chen
Jie Sun
Pingyan Shen
Zijin Chen
Wen Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1466323

3,011 views

Original Research

Published on 24 Jan 2025

Cresp®: transforming the landscape of chemotherapy-induced anemia - a comprehensive retrospective real-world analysis in 523 Indian patients

in Hematologic Malignancies

MV Chandrakanth
Vivek Agarwala
Pranav Sopory
Himadri Nayak
Purvish M. Parikh
Minakshi Roy
Rajib De
Pradeep Narayan
Anjuli Tuladhar Barai
Kaustav Mandal

Frontiers in Oncology

doi 10.3389/fonc.2025.1418327

3,205 views
1 citation

Review

Published on 21 Jan 2025

BCL-2 inhibitors in hematological malignancies: biomarkers that predict response and management strategies

in Hematologic Malignancies

Mariam Markouli
Maria N. Pagoni
Panagiotis Diamantopoulos

Frontiers in Oncology

doi 10.3389/fonc.2024.1501950

4,946 views
4 citations

2,001 articles

articles

Associations of ANGPT2 expression and its variants (rs1868554 and rs7825407) with multiple myeloma risk and outcome

Lipid metabolism in multiple myeloma: pathogenesis, therapeutic opportunities, and future directions

Advancing the understanding and management of angioimmunoblastic T-cell lymphoma: insights into its pathogenesis, clinical features, and emerging therapeutic strategies

Retrospective study of chidamide-containing regimens as maintenance therapy among T- and NK-cell lymphoma patients

Identification of subgroups of early-stage mycosis fungoides patients with increased itch and impaired quality of life

Tumor gene expression signatures associated with outcome in large B−cell lymphoma treated with CD19-directed CAR T−cell therapy (axicabtagene ciloleucel)

Prognostic impact of initial platelet count and post-induction platelet recovery in elderly AML patients: associated with circulating cytokines

Editorial: MDS: new scientific and clinical developments

Mast cell leukemia: a rare case report and literature review

Case Report: A case series on histiocytic sarcoma – various clinical features and patient outcomes

Exploration of risk factors and characteristics of COVID-19 infection among patients with hematological malignancies in Suzhou, China: a retrospective study

Association of ANA and SSA autoantibodies with progression-free survival in multiple myeloma: a retrospective cohort study

Influence of CAR T-cell therapy associated complications

Prognostic value of serum lipids in newly diagnosed acute promyelocytic leukemia

Longitudinal study of cognitive and mental functions among adult Hodgkin-lymphoma survivors, based on data from a primary treatment center in Hungary

The impact of multiple myeloma drugs treatments on autologous stem cell transplantation in the era of new drugs

Radiotherapy as a primary treatment modality for a young man with a primary urethral plasmacytoma: case report and literature review

A novel truncated fusion gene ETV6::AC010198.2 in post-MPN acute myeloid leukemia caused by del(12)(p13p11)

Psychometric properties and meaningful change thresholds for the QOL-E instrument in patients with myelodysplastic neoplasms

Unusual symptoms reveal a rare splenic lymphoma: a case report of PS-DLBCL with neck and shoulder pain as the initial presentation

Prognostic and clinicopathological role of soluble programmed cell death ligand-1 in patients with diffuse large B-cell lymphoma: a meta-analysis

Daratumumab treatment for kidney-involved light chain deposition disease prevents renal function progression: a case report with 3 years of follow-up and review of the literature

Cresp®: transforming the landscape of chemotherapy-induced anemia - a comprehensive retrospective real-world analysis in 523 Indian patients

BCL-2 inhibitors in hematological malignancies: biomarkers that predict response and management strategies